Unilever share price slips on Alicorp deal: what ULVR investors are watching next
29 January 2026
2 mins read

Unilever share price slips on Alicorp deal: what ULVR investors are watching next

London, January 29, 2026, 08:32 (GMT) — Regular session

  • Unilever shares edged down about 0.5% in early London trading
  • Company agreed to sell its Home Care business in Colombia and Ecuador to Alicorp, the Peruvian company
  • Investors are shifting focus to Unilever’s mid-February earnings, eager to spot any fresh moves in the company’s portfolio

Unilever’s shares dipped in early London trading Thursday after the company sold its home care business in Colombia and Ecuador to Peruvian rival Alicorp. By 08:32 GMT, the stock was down 0.45% at 4,793.75 pence. 1

Investors want steady, reliable growth from major consumer staples companies—not just price increases and cost cuts. Unilever has talked more about “sharpening” its portfolio, and this deal represents another small step in that direction.

With no price disclosed, the market is left guessing the deal’s value. Attention now shifts to what other assets could be on the block and whether selling them genuinely boosts execution or just slices through the company’s layers.

Unilever revealed the sale covers local household and laundry brands like Fab, 3D, Aromatel, and Deja. The transaction still needs regulatory approval and must meet standard closing conditions. “It aligns with our ambition to sharpen our portfolio and focus on the categories where we can lead, innovate and grow sustainably,” said Reginaldo Ecclissato, President of Unilever Markets. 2

Alicorp called the transaction an asset purchase. According to a filing with Peru’s securities regulator (SMV), its subsidiaries in Colombia and Ecuador have inked agreements to buy 100% of Unilever’s home care business assets in those countries. The deal awaits regulatory approval in both markets. No financial terms or timelines were disclosed. 3

Unilever’s team in Ecuador insisted business will proceed normally. Marcos Dueñas, general manager of Unilever Ecuador, said the decision followed a portfolio review. “Alicorp knows the category well,” he told the local news outlet Primicias. The transition won’t affect operations. 4

An adviser on the transaction shared a similar perspective. Inverlink, acting as Unilever’s financial adviser for the sale, described the move as consistent with Unilever’s strategy to concentrate on its core “power brands.” They also noted the deal is expected to accelerate Alicorp’s expansion throughout the Andean region. 5

Home care, which includes detergents, cleaners, and laundry products, continues to be a fiercely contested sector. Unilever is up against heavyweight rivals such as Procter & Gamble and Reckitt, plus strong local contenders. Smaller, country-specific portfolios may generate profits, but they tend to sap management focus and marketing budgets.

The deal awaits regulatory approval, with authorities able to prolong the review or attach conditions in critical areas. Since terms remain undisclosed, investors are left guessing the proceeds and whether this sale signals a simple exit or part of a larger strategic reshuffle.

Unilever’s Q4 and full-year 2025 results are due Feb. 12, marking the next key date. Investors will watch closely for news on disposals, reinvestment strategies, and the 2026 demand outlook. The company is also lined up to speak at the CAGNY Conference on Feb. 17. 6

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Lloyds Bank launches £1.75bn buyback after profit beat, even as motor finance bill swells
Previous Story

Lloyds Bank launches £1.75bn buyback after profit beat, even as motor finance bill swells

Canara Bank Q3 results: Profit jumps 26% but shares slide as Budget jitters hang over Nifty
Next Story

Canara Bank Q3 results: Profit jumps 26% but shares slide as Budget jitters hang over Nifty

Go toTop